ADVERTISEMENT

First RSV Vaccine for Infants, Older Adults Approved for EU marketing

Liz Scherer   |   Medical News   |   21 July 2023
ADVERTISEMENT

The first vaccine to protect infants under 6 months of age and adults 60 years and older against respiratory syncytial virus (RSV) will soon be available in Europe, following marketing authorisation by the European Medicines Agency (EMA). Abrysvo (bivalent, recombinant, Pfizer) which received marketing approval by the U.S. Food & ...

          

September Challenge

Ends in 5d 18h
left
right

Topic Challenges

left
right